Blog

If you are looking to support your brain and enhance your cognition, start incorporating these four herbs and spices that have been well studied for their impressive brain health benefits.

Ashwagandha is an evergreen shrub native to areas in India and the Middle East which has been used for centuries in Ayurvedic medicine, that has gained massive popularity as a brain supporting supplement.

Oils can either contribute to disease and inflammation or provide important fats and nutrients to prevent chronic illness. Make sure that you are utilizing an oil that is contributing to your good health.

Research shows that eating certain foods, such as those found in the MIND diet, slows brain aging by 7.5 years, which ultimately lessens the chances of developing Alzheimer’s Disease.

For our final blog post of 2020, we want to share with you the top 3 blog posts from this year.

Dark chocolate is a decadent indulgence, but it also contains incredible health benefits. Here we describe what to look for when purchasing dark chocolate to ensure you reap the benefits of this delicious treat!

We should seek treatments that impact as many of these variables as possible, and which are individualized to meet our specific needs. And we should seek treatment early.

We need the micronutrients from a wide variety of plant foods in order to fight neurodegeneration. These are the best cooking methods and techniques to maximize nutrient bioavailability.

The Bredesen Protocol draws on the natural power of food to fight cognitive decline. Keep the following items on hand if you're eating to maximize brain health.

The longevity diet is essentially an adaptation from Okinawan and Mediterranean diets, which focus on whole, plant-based foods, specifically complex carbohydrates and healthy fats such as beans, cruciferous vegetables, nuts and olive oil.

Peperonata, an Italian stewed pepper dish, is full of flavor and packed with nutrition. This dish is delicious on its own or served with poached eggs or grilled fish.

Last week, an FDA panel rejected arguments in favor of Biogen's highly anticipated drug, aducanumab.